Global Veterinary Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The veterinary Biomarkers Market is Segmented by Product Type (Biomarkers, Kits, Reagents, and Biomarker Readers), Animal Type (Companion animals and Production animals), Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumors, and Others), Application (Disease Diagnostic, Preclinical Research, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.

Global Veterinary Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Veterinary Biomarkers Industry Overview

The market for veterinary biomarkers is emerging and consolidating. Leading players deploy numerous strategic initiatives that include competitive pricing strategies, partnerships, product expansion, sales and marketing initiatives, and mergers and acquisitions. Among the market's key players are Zoetis, Virbac, Life Diagnostics, Acuvet Biotech, Merck & Co., Idexx Laboratories, Inc., MI: RNA Diagnostics Ltd., Mercodia Ab, Antech Diagnostics, Inc., and Avacta Life Sciences Limited. The market players are introducing cutting-edge biomarker-based solutions to strengthen their position as the industry's leaders.

Veterinary Biomarkers Market Leaders

  1. Zoetis

  2. Virbac

  3. Life Diagnostics

  4. Merck & Co

  5. Acuvet Biotech

  6. *Disclaimer: Major Players sorted in no particular order
Veterinary.png